Philadelphia-negative secondary acute myeloid leukaemia during imatinib treatment for chronic phase chronic myeloid leukaemia

被引：9
|
作者：
Ross, David M.
Jackson, Sharon R.
Browett, Peter J.
机构：
[1] Inst Med & Vet Sci, Div Hematol, Adelaide, SA 5000, Australia
[2] Middlemore Hosp, Dept Haematol, Auckland, New Zealand
[3] Univ Auckland, Dept Mol Med & Pathol, Auckland 1, New Zealand
来源：
LEUKEMIA & LYMPHOMA | 2007年 / 48卷 / 06期
关键词：
D O I：
10.1080/10428190701297360
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1231 / 1233
页数：3
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS ANALYSIS OF NILOTINIB VERSES IMATINIB FOR THE TREATMENT OF CHRONIC PHASE PHILADELPHIA CHROMOSOME POSITIVE CHRONIC MYELOID LEUKAEMIA
    Mildred, M.
    Ward, S.
    Squires, H.
    Gray, E.
    HAEMATOLOGICA, 2012, 97 : 314 - 314
  • [22] An audit of the use of imatinib in the treatment of chronic myeloid leukaemia in Scotland
    Johnson, PRE
    Dhanapala, C
    Maguire, C
    White, J
    Drummond, M
    Shepherd, PCA
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 : 17 - 17
  • [23] Managing chronic myeloid leukaemia in the elderly with intermittent imatinib treatment
    D Russo
    M Malagola
    C Skert
    V Cancelli
    D Turri
    P Pregno
    M Bergamaschi
    M Fogli
    N Testoni
    A De Vivo
    F Castagnetti
    E Pungolino
    F Stagno
    M Breccia
    B Martino
    T Intermesoli
    G R Cambrin
    G Nicolini
    E Abruzzese
    M Tiribelli
    C Bigazzi
    E Usala
    S Russo
    A Russo-Rossi
    M Lunghi
    M Bocchia
    A D'Emilio
    V Santini
    M Girasoli
    R Di Lorenzo
    S Bernardi
    A Di Palma
    B M Cesana
    S Soverini
    G Martinelli
    G Rosti
    M Baccarani
    Blood Cancer Journal, 2015, 5 : e347 - e347
  • [24] Acute generalized exanthematous pustulosis (AGEP) secondary to imatinib in a patient with chronic myeloid leukaemia
    Scott, A. D.
    Lee, M.
    Kubba, F.
    Chu, A.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2015, 40 (08) : 926 - 927
  • [25] Managing chronic myeloid leukaemia in the elderly with intermittent imatinib treatment
    Russo, D.
    Malagola, M.
    Skert, C.
    Cancelli, V.
    Turri, D.
    Pregno, P.
    Bergamaschi, M.
    Fogli, M.
    Testoni, N.
    De Vivo, A.
    Castagnetti, F.
    Pungolino, E.
    Stagno, F.
    Breccia, M.
    Martino, B.
    Intermesoli, T.
    Cambrin, G. R.
    Nicolini, G.
    Abruzzese, E.
    Tiribelli, M.
    Bigazzi, C.
    Usala, E.
    Russo, S.
    Russo-Rossi, A.
    Lunghi, M.
    Bocchia, M.
    D'Emilio, A.
    Santini, V.
    Girasoli, M.
    Di Lorenzo, R.
    Bernardi, S.
    Di Palma, A.
    Cesana, B. M.
    Soverini, S.
    Martinelli, G.
    Rosti, G.
    Baccarani, M.
    BLOOD CANCER JOURNAL, 2015, 5 : e347 - e347
  • [26] RESULT OF IMATINIB USE IN CHINESE PATIENTS WITH CHRONIC MYELOID LEUKAEMIA IN CHRONIC PHASE
    Li, V.
    Liu, H. S. Y.
    Chan, F. H. Y.
    Lau, T. K. H.
    Kho, B. C. S.
    Yip, S. F.
    Liang, Y. S.
    Chu, R.
    Chan, J. C. W.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 498 - 499
  • [27] Mesenchymal stem cells of patients with chronic myeloid leukaemia are Philadelphia negative
    Gentilini, C
    Al-Ali, KH
    Reinhardt, A
    Bartsch, K
    Lange, T
    Niederwieser, DW
    BONE MARROW TRANSPLANTATION, 2005, 35 : S237 - S237
  • [28] The blast phase of chronic myeloid leukaemia
    Silver, Richard T.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2009, 22 (03) : 387 - 394
  • [29] First line treatment of chronic phase chronic myeloid leukaemia patients with the generic formulations of imatinib mesylate
    Eskazan, Ahmet Emre
    Ayer, Mesut
    Kantarcioglu, Bulent
    Arica, Deniz
    Demirel, Naciye
    Aydin, Demet
    Yalniz, Fevzi Firat
    Elverdi, Tugrul
    Salihoglu, Ayse
    Ar, Muhlis Cem
    Aydin, Seniz Ongoren
    Baslar, Zafer
    Aydin, Yildiz
    Tuzuner, Nukhet
    Ozbek, Ugur
    Soysal, Teoman
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 167 (01) : 139 - 141
  • [30] Position paper on imatinib mesylate in chronic myeloid leukaemia
    O'Brien, SG
    Rule, SAJ
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 119 (01) : 268 - 272
12345